Alight Reports 2026 Alternate Medical Plan Enrollment Doubled from 2025
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Dec 18 2025
0mins
Source: Newsfilter
- Enrollment Trend Shift: Alight's analysis of 9.5 million users shows that alternate medical plan enrollments doubled in 2026 from 2025, with the fastest growth among lower-income employees, indicating new opportunities for employers to enhance their benefits strategies.
- Rising Medical Costs: The median medical cost for single employees rose by 9.8% in 2026, while family costs surged to 16.8%, which not only increases the financial burden on employees but also compels companies to reassess their benefits offerings.
- Widening Income Gap: Medical enrollment rates for lower-income employees dropped from 50% in 2025 to 47% in 2026, while high-income employees maintained an 86% enrollment rate, highlighting the significant impact of income levels on healthcare choices.
- Increased AI Utilization: From October to December 2025, interactions with Alight's AI chatbot exceeded 8.5 million, nearly tripling from the previous year, indicating a significant increase in employee trust in AI for benefits decision-making.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy ALIT?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on ALIT
Wall Street analysts forecast ALIT stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for ALIT is 4.00 USD with a low forecast of 2.50 USD and a high forecast of 6.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
4 Analyst Rating
4 Buy
0 Hold
0 Sell
Strong Buy
Current: 1.610
Low
2.50
Averages
4.00
High
6.00
Current: 1.610
Low
2.50
Averages
4.00
High
6.00
About ALIT
Alight, Inc. is a cloud-based human capital technology and services provider. It is engaged in delivering human capital management solutions to various organizations. This includes the implementation and administration of employee benefits (health, wealth, and leaves benefits) solutions. It allows participants to access their solutions digitally, including through a mobile application on Alight Worklife, its intuitive, cloud-based employee engagement platform. Through Alight Worklife, the Company provides an enterprise level, integrated offering designed to drive better outcomes for organizations and individuals. Its primary business, Employer Solutions, is driven by its Alight Worklife platform, and includes integrated benefits administration, healthcare navigation, financial wellbeing, leave of absence management and retiree healthcare. The Company also has Sword Health, which is an AI care platform that delivers clinical-grade care across various health conditions.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Alight Inc and Other Industrials Stocks Oversold with RSI Near 30
- Alight Inc Rating Adjustment: Keybanc analyst maintains an Overweight rating on Alight but lowers the price target from $6 to $2.5, resulting in a 20% stock decline over the past month, with an RSI of 29.4 indicating potential undervaluation.
- Clarivate PLC Downgrade Impact: Goldman Sachs analyst downgrades Clarivate from Buy to Neutral and cuts the price target from $4.2 to $3.6, leading to a 19% stock drop in the past month, with an RSI of 29 suggesting a possible short-term rebound opportunity.
- CBIZ Inc New Rating: Deutsche Bank initiates coverage on CBIZ with a Hold rating and a price target of $60, despite a 16% stock decline over the past five days, with an RSI of 27.6 indicating signs of being undervalued.
- Market Signal Analysis: Benzinga Pro signals indicate a potential breakout for CBIZ shares, even as its stock dipped 2.6% to $44.97 on Wednesday, reflecting market interest and potential investment opportunities.
Continue Reading
Low-Cap Industrial Stocks Face Weak EPS Revisions
- EPS Revision Analysis: As the earnings season approaches, several mid to low-cap industrial stocks have received an 'F' grade for earnings momentum, indicating significant downward pressure on analyst expectations for future earnings.
- Affected Companies: Companies such as Alight (ALIT), Alaska Air Group (ALK), and Apogee Enterprises (APOG) have all received an 'F' grade, highlighting severe challenges to their earnings outlook.
- Market Reaction Expectations: These companies may face cautious investor sentiment due to factors like heavy debt and high customer churn rates, which could negatively impact their stock performance.
- Industry Outlook: Despite the current poor EPS revision grades, the market remains optimistic about the industrial sector's prospects for 2026, potentially providing support for future investment opportunities.
Continue Reading